CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CLD HEALTH OUTCOMES
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS) THROMBOCYTOPENIA
NASH
CHOLESTATIC
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Board of Advisors/Faculty CLDF Committees 2023 GI Fellow Board of Advisors
Embassy of Education
Slide Library Publications Webcasts Algorithm Abstract Library Committee Members
 
HCC-Single Disease Content  
HCC Care Cascade Decision-Support Tool
 
Publications
 
Webcasts
     
HCC Epidemiology and Care Cascade Recommendations   Educational Webcast
New Advances in HCC Therapies   Educational Webcast
Slide Library
   Released: 2023
test
HCC Epidemiology and Care Cascade Recommendations
15 slides
 
 
   Released: 2022
test
New Advances in HCC Therapies
61 slides
 
 
   Released: 2021
test
Management and Treatment of HCC is Optimized in a Multidisciplinary Liver Tumor Board
61 slides
 
 
   Released: 2021
test
Sequence of Currently Approved Systemic Therapies for HCC: From First Line to Second Line and Beyond
53 slides
 
 
   Released: 2021
test
The Role of Precision Medicine in the Management and Treatment of HCC
33 slides
 
 
   Released: 2021
test
Integration of Immuno-Oncology to Improve HCC Outcomes: Immune Checkpoint Inhibition and Potential Synergies with Interventional Radiology and Radiation Oncology
30 slides
 
 
   Released: 2021
test
Non-Cirrhotic Risk Factors for HCC in Patients with NAFLD
35 slides
 
 
   Released: 2021
test
Recommendations to Optimize Surveillance of HCC
33 slides
 
 
   Released: 2021
test
Epidemiology and Surveillance for Hepatocellular Carcinoma
31 slides
 
 
   Released: 2021
test
Current Surgical Resection for Primary Liver Malignancies
87 slides
 
 
   Released: 2021
test
Second Line Therapies in HCC
30 slides
 
 
   Released: 2021
test
Thermal Ablation for HCC
96 slides
 
 
   Released: 2021
test
Transarterial Therapies for HCC: TACE and Y90
38 slides
 
 
   Released: 2021
test
Imaging of HCC Surveillance, Diagnosis, and Prognosis
38 slides
 
 
   Released: 2021
test
Update on the Front-Line Management of Advanced HCC
33 slides
 
 
   Released: 2021
test
Liver Transplantation for Patients with Hepatocellular Carcinoma
33 slides
 
 
   Released: 2021
test
HCC Research Update: From Bedside to Bench-side and Back to Bedside
26 slides
 
 
   Released: 2020
test
How to Approach HCV Treatment in Patients With HCC - DAA Before or After Liver Transplantation
40 slides
 
 
   Released: 2020
test
Down-Staging of Hepatocellular Carcinoma Before Liver Transplantation: Tumor Burden, Alpha-Fetoprotein and Wait Time Predict of Tumor Biology
45 slides
 
 
   Released: 2020
test
HCC Risk Biomarkers 2021: State of the Art and Future Perspective
65 slides
 
 
   Released: 2020
test
Novel Treatments and Emerging Targets for Hepatocellular Carcinoma (HCC)
52 slides
 
 
   Released: 2020
test
Surgical Options for Treatment of HCC - Resection vs. Liver Transplantation (LT)
74 slides
 
 
   Released: 2020
test
Interventional Oncology: Hepatocellular Carcinoma
63 slides
 
 
   Released: 2020
test
Update on HCC Clinical Trials: Barcelona HCC Criteria and Phase III Data
60 slides
 
 
   Released: 2020
test
Disparities in Linkage to Care for HCC
35 slides
 
 
   Released: 2020
test
HCC Surveillance in an Era of Biomarkers: Application of State-of-the-Art Tools
59 slides
 
 
   Released: 2020
test
Overview of Treatment Approaches to Hepatocellular Carcinoma
47 slides
 
 
   Released: 2020
test
Diagnosis and Staging of HCC
38 slides
 
 
   Released: 2020
test
Global HCC Trends: Implications for Prevention
54 slides
 
 
   Released: 2020
test
Changing Epidemiology of HCC in the U.S.
55 slides
 
 
   Released: 2020
test
Populations at High Risk for HCC in the U.S. - Implications for Clinical Practice
59 slides
 
 
   Released: 2019
test
Epidemiology HCC Innovations
21 slides
 
 
   Released: 2019
test
Intra-Arterial Therapies
25 slides
 
 
   Released: 2019
test
Immunotherapy for HCC and Emerging Treatments
72 slides
 
 
   Released: 2019
test
Liver Transplant for Hepatocellular Carcinoma
22 slides
 
 
   Released: 2019
test
Systemic Therapy for Liver Cancer
46 slides
 
 
   Released: 2019
test
Imaging and Biomarkers in HCC: Diagnosis and Surveillance
29 slides
 
 
   Released: 2019
test
Defining Outcomes of Hepatocellular Carcinoma therapy
51 slides
 
 
   Released: 2019
Webcast
Determining Hepatocellular Carcinoma Staging:Liver Disease Staging, Performance Status and RECIST Criteria
38 slides
 
 
   Released: 2019
Webcast
Surveillance for Hepatocellular Carcinoma
37 slides
 
 
   Released: 2018
test
Hepatology News Tonight: Managing Complication of Cirrhosis
57 slides
 
   
 
 
Abstract Library
1.MAFLD: an optimal framework for understanding liver cancer phenotypes
 

J Gastroenterol. 2023 Jul 20. doi: 10.1007/s00535-023-02021-7.Online ahead of print.

 

Harry Crane 1 2, Cameron Gofton 3 4, Ankur Sharma 5 6, Jacob George 3
 
2.Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution
 

Life (Basel). 2023 Jul 14;13(7):1562. doi: 10.3390/life13071562.

 

Silvia Cesario 1, Virginia Genovesi 1, Francesca Salani 2, Enrico Vasile 1, Lorenzo Fornaro 1, Caterina Vivaldi 1 3, Gianluca Masi 1 3
 
3.Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review
 

Cancers (Basel). 2023 Jun 27;15(13):3367. doi: 10.3390/cancers15133367.

 

Samuel J Martínez-Domínguez 1 2 3, Sandra García-Mateo 1 2 3, Viviana Laredo 1 2 3, Carla J Gargallo-Puyuelo 1 2 3, Beatriz Gallego Llera 2, Julia López de la Cruz 1 2 3, Fernando Gomollón 1 2 3 4
 
4.Guideline Review: European Association for the Study of Liver (EASL) Clinical Practice Guidelines on Haemochromatosis
 

J Clin Exp Hepatol. 2023 Jul-Aug;13(4):649-655. doi: 10.1016/j.jceh.2022.11.003.Epub 2022 Nov 11.

 

James Liu Yin 1, Christopher Cussen 2, Christopher Harrington 3 4, Pierre Foskett 4, Kishor Raja 5, Aftab Ala 1 2 6
 
5.Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal Meeting
 

J Gastrointest Cancer. 2023 Jun;54(2):672-676. doi: 10.1007/s12029-022-00849-5.Epub 2022 Jul 19.

 

Sepideh Gholami 1, Mustafa Abidalhassan 2, May Cho 3, Anwaar Saeed 4, Flavio G Rocha 5
 
6.Evaluation of the Safety and Efficacy of Conventional Transarterial Chemoembolization (cTACE) and Drug-Eluting Bead (DEB)-TACE in the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review
 

Cureus. 2023 Jul 16;15(7):e41943. doi: 10.7759/cureus.41943. eCollection 2023 Jul.

 

Javaria Ayyub 1, Karan Nareshbhai Dabhi 1, Namra V Gohil 2 1, Nida Tanveer 1, Sally Hussein 1, Shravya Pingili 3 4, Vijaya Krishna Makkena 5 1, Arturo P Jaramillo 6, Babatope L Awosusi 7, Tuheen Sankar Nath 8 9
 
7.NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models
 

Cancers (Basel). 2023 Jul 22;15(14):3723. doi: 10.3390/cancers15143723.

 

Jing Fang 1 2, Séverine Celton-Morizur 1 2, Chantal Desdouets 1 2
 
8.Friend or Foe? Locoregional Therapies and Immunotherapies in the Current Hepatocellular Treatment Landscape
 

Int J Mol Sci. 2023 Jul 14;24(14):11434. doi: 10.3390/ijms241411434.

 

Shamar Young 1, Jack Hannallah 1, Dan Goldberg 1, Tina Sanghvi 2, Junaid Arshad 3, Aaron Scott 3, Gregory Woodhead 1
 
9.A review of liver fibrosis and cirrhosis regression
 

J Pathol Transl Med. 2023 Jul;57(4):189-195. doi: 10.4132/jptm.2023.05.24.Epub 2023 Jun 20.

 

Michael J Lee 1
 
10.The Effect of Aspirin Use on Incident Hepatocellular Carcinoma-An Updated Systematic Review and Meta-Analysis
 

Cancers (Basel). 2023 Jul 6;15(13):3518. doi: 10.3390/cancers15133518.

 

Jonathan Abdelmalak 1 2, Natassia Tan 1 2, Danny Con 3, Guy Eslick 4, Ammar Majeed 1 2, William Kemp 1 2, Stuart K Roberts 1 2
 
11.New Opportunities to Individualize Frontline Therapy in Advanced Stages of Hepatocellular Carcinoma
 

Drugs. 2023 Aug;83(12):1091-1109. doi: 10.1007/s40265-023-01907-3.Epub 2023 Jul 4.

 

John D Gordan 1 2, Bridget P Keenan 3 4, Huat Chye Lim 3 5, Mark Yarchoan 6, R Katie Kelley 3 4
 
12.Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma
 

Biology (Basel). 2023 Jul 11;12(7):984. doi: 10.3390/biology12070984.

 

Riccardo Nevola 1 2, Giovanni Tortorella 1, Valerio Rosato 2, Luca Rinaldi 1, Simona Imbriani 1, Pasquale Perillo 2, Davide Mastrocinque 2, Marco La Montagna 1, Antonio Russo 3, Giovanni Di Lorenzo 1, Maria Alfano 1, Maria Rocco 1, Carmen Ricozzi 1, Klodian Gjeloshi 1, Ferdinando Carlo Sasso 1, Raffaele Marfella 1, Aldo Marrone 1, Loreta Anesti Kondili 4, Nicolino Esposito 2, Ernesto Claar 2, Domenico Cozzolino 1
 
13.Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects
 

Curr Treat Options Oncol. 2023 Jul;24(7):711-724.doi: 10.1007/s11864-023-01098-9. Epub 2023 Apr 27.

 

Basil Alawyia 1, Constantina Constantinou 2
 
14.Considerations for individualized first-line systemic treatment in advanced hepatocellular carcinoma
 

Curr Opin Pharmacol. 2023 Jun;70:102365. doi: 10.1016/j.coph.2023.102365.Epub 2023 Mar 25.

 

Frederik Peeters 1, Jeroen Dekervel 2
 
15.Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma
 

Cancers (Basel). 2023 Jul 15;15(14):3629. doi: 10.3390/cancers15143629.

 

Pietro Guerra 1, Andrea Martini 1, Patrizia Pontisso 1, Paolo Angeli 1
 
16.Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
 

Lancet Oncol. 2023 Jul;24(7):e312-e322. doi: 10.1016/S1470-2045(23)00186-9.

 

Alessandro Vitale 1, Giuseppe Cabibbo 2, Massimo Iavarone 3, Luca Viganò 4, David J Pinato 5, Francesca Romana Ponziani 6, Quirino Lai 7, Andrea Casadei-Gardini 8, Ciro Celsa 9, Giovanni Galati 10, Martina Gambato 11, Laura Crocetti 12, Matteo Renzulli 13, Edoardo G Giannini 14, Fabio Farinati 11, Franco Trevisani 15, Umberto Cillo 11; HCC Special Interest Group of the Italian Association for the Study of the Liver

 

Collaborators

  • HCC Special Interest Group of the Italian Association for the Study of the Liver:

Umberto Baccarani, Giuseppina Brancaccio, Raffaele Cozzolongo, Alessandro Cucchetti, Nicoletta De Matthaeis, Stefano Di Sandro, Simone Famularo, Michele Finotti, Francesco G Foschi, Davide Ghinolfi, Marco Guarracino, Salvatore Gruttadauria, Maria Guarino, Alba Kostandini, Ilaria Lenci, Giovanni B Levi Sandri, Tommaso M Manzia, Giovanni Marasco, Mario Masarone, Chiara Mazzarelli, Fabio Melandro, Luca Miele, Filomena Morisco, Daniele Nicolini, Duilio Pagano, Filippo Pelizzaro, Giulia Pieri, Fabio Piscaglia, Maria Corina Plaz Torres, Riccardo Pravisani, Maria Rendina, Fabrizio Romano, Francesco P Russo, Rodolfo Sacco, Angelo Sangiovanni, Carlo Sposito, Raffaella Tortora, Francesco Tovoli, Mauro Viganò, Paola Violi
 
17.Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
 

Curr Oncol. 2023 Jun 18;30(6):5863-5875. doi: 10.3390/curroncol30060439.

 

Samantha M Ruff 1, Ashish Manne 2, Jordan M Cloyd 1, Mary Dillhoff 1, Aslam Ejaz 1, Timothy M Pawlik 1
 
18.Non-Classical HLA Class 1b and Hepatocellular Carcinoma
 

Biomedicines. 2023 Jun 9;11(6):1672. doi: 10.3390/biomedicines11061672.

 

Valli De Re 1, Maria Lina Tornesello 2, Vito Racanelli 3, Marcella Prete 3, Agostino Steffan 1
 
19.Recent advances in the management of hepatocellular carcinoma
 

Clin Mol Hepatol. 2023 Jul 21. doi: 10.3350/cmh.2023.0125. Online ahead of print.

 

Kamya Sankar 1, Jun Gong 1, Arsen Osipov 1, Steven A Miles 1, Kambiz Kosari 1 2, Nicholas N Nissen 1 2, Andrew E Hendifar 1, Ekaterina K Koltsova 1 3, Ju Dong Yang 1 2 4
 
20.Optimizing liver transplant prioritization for hepatocellular carcinoma through risk stratification
 

Curr Opin Organ Transplant. 2023 Aug 1;28(4):265-270.doi: 10.1097/MOT.0000000000001080. Epub 2023 Jun 19.

 

Joshua Norman 1, Neil Mehta 2, Allison Kwong 3
 
21.LKB1 signaling and patient survival outcomes in hepatocellular carcinoma
 

Pharmacol Res. 2023 Jun;192:106757. doi: 10.1016/j.phrs.2023.106757.Epub 2023 Apr 5.

Khoa Nguyen 1, Katherine Hebert 2, Emily McConnell 2, Nicole Cullen 2, Thomas Cheng 2, Susanna Awoyode 2, Elizabeth Martin 2, Weina Chen 3, Tong Wu 3, Suresh K Alahari 4, Reza Izadpanah 5, Bridgette M Collins-Burow 2, Sean B Lee 3, David H Drewry 6, Matthew E Burow 7
 
22.Prognostic value of genotyping in hepatocellular carcinoma: A systematic review
 

J Viral Hepat. 2023 Jul;30(7):582-587. doi: 10.1111/jvh.13833. Epub 2023 Mar 22.

 

Sylvain Bodard 1 2 3, Yan Liu 4 5, Sylvain Guinebert 1 2, Kherabi Yousra 2, Tarik Asselah 2 6
 
23.Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice
 

Lancet Gastroenterol Hepatol. 2023 Aug;8(8):760-770.doi: 10.1016/S2468-1253(23)00147-4. Epub 2023 Jun 14.

 

Matthias Pinter 1, Bernhard Scheiner 2, David J Pinato 3
 
24.Barriers to palliative care in hepatocellular carcinoma: A review of the literature
 

J Gastroenterol Hepatol. 2023 Jul;38(7):1047-1055. doi: 10.1111/jgh.16107.Epub 2023 Jan 23.

 

Mostafa Abasseri 1, Shakira Hoque 2, B A Slavica Kochovska 3 4, Kim Caldwell 5, Linda Sheahan 6 7 8 9, Amany Zekry 1 2 8
 
25.More efficient and inclusive time-to-event trials with covariate adjustment: a simulation study
 

Trials. 2023 Jun 6;24(1):380. doi: 10.1186/s13063-023-07375-0.

 

Raphaëlle Momal # 1, Honghao Li # 1, Paul Trichelair 1, Michael G B Blum 1, Félix Balazard 2
 
View More
 
Sponsored Content
 
 
Thank you to our Sponsors
 
 

HEPATITIS

HBV
HCV
HDV

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

NASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

PBC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2023 GI Fellow Board of Advisors

Other Resources

Journal Abstracts
Hep C Link to Care

Subscribe

Be the first to know about our latest upcoming programs and events!
CLDF

Follow us
Facebook
Twitter
Youtube
LiverQ
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2023 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.